In order to generate new drug candidates for cancer therapy, chemistry effort succeeded in identifying T-3764518 (Fig 1), which had an IC50 of 4.7 nM against recombinant SCD1 enzymatic activity [24]. The gene discussed is SCD; the disease is cancer.